Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway

Yang, A. H. (2006). A Simple Way to Recognize Non-Diabetic Nephropathies in Diabetic Patients. Acta Nephrologica, 20(1), 16-16. https://www.airitilibrary.com/Article/Detail?DocID=10131671-200601-20-1-16-16-a
T, L., M, S., & A, P. (2015). Role of Inflammation in the Pathogenesis of Diabetic Nephropathy. International Journal of Diabetology & Vascular Disease Research (IJDVR), 3(6), 108-112. https://www.airitilibrary.com/Article/Detail?DocID=P20151016001-201507-201510160006-201510160006-108-112
鄭竹芸（2011）。Role of PI3K/mTOR/S6K1 signaling pathway in Diabetic Nephropathy〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2907201121304600
梁家瑋（2010）。Roles of Histone Deacetylase SIRT1 in Diabetic Nephropathy〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://doi.org/10.6832/KMU.2010.00132
李明翰（2012）。Role of Transcription Factor MTA1 in Diabetic Nephropathy〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2408201213445500